Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gene therapy: progress and challenges.

F Meyer1, M Finer

  • 1Aventis Pharma/Gencell, Vitry-s-Seine, France. francois.meyer@aventis.com

Cellular and Molecular Biology (Noisy-Le-Grand, France)
|February 13, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Occupational medicine aspects in general and abdominal surgery -- risk of infection attributable to needlestick injuries (what the surgeon should know)].

Zentralblatt fur Chirurgie·2013
Same author

[Work strain by anaesthetic gas and surgical smoke due to tissue coagulation as well as safety measures in surgical operating rooms - what the surgeon needs to know].

Zentralblatt fur Chirurgie·2013
Same author

[Organ-invasive carcinoma of the pararenal gland involving the inferior vena cava: successful curative and interdisciplinary surgical management].

Deutsche medizinische Wochenschrift (1946)·2013
Same author

[The Joint Annual Congress of "DGVS"/"DGAV" 2011 - Selected Topics Outlined by Organiser & Participant, Gastroenterologist & Abdominal Surgeon].

Zentralblatt fur Chirurgie·2013
Same author

Non-equivalent carbon atoms in the resonant inelastic soft X-ray scattering map of cysteine.

The Journal of chemical physics·2013
Same author

[Surgical treatment of gastric carcinoma. German multicenter observational studies].

Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen·2013
Same journal

Differential effects of high-sucrose and high-fat diets on metabolic syndrome, BBB integrity, and hippocampal Aβ accumulation.

Cellular and molecular biology (Noisy-le-Grand, France)·2026
Same journal

CRISPR systems in cancer therapeutics and diagnostics.

Cellular and molecular biology (Noisy-le-Grand, France)·2026
Same journal

Sex-specific effects of fluoxetine on REM sleep deprivation-induced behavioral impairments and BDNF downregulation in rats.

Cellular and molecular biology (Noisy-le-Grand, France)·2026
Same journal

Gene polymorphism and serum level of RANKL among patients with rheumatoid arthritis: a systematic review and meta-analysis.

Cellular and molecular biology (Noisy-le-Grand, France)·2026
Same journal

Effect of peniocerol on human meniscal fibrochondrocyte inflammation induced by IL-1β and TNF-α through the NF-κB signaling pathway.

Cellular and molecular biology (Noisy-le-Grand, France)·2026
Same journal

Integrated density functional theory, molecular docking, and pharmacokinetic modeling of mukonal and its derivatives as inhibitors of the Plasmodium falciparum TFIIH complex (Tfb5 subunit).

Cellular and molecular biology (Noisy-le-Grand, France)·2026
See all related articles

Gene therapy uses vectors to deliver genetic material for disease treatment. Recent advancements have significantly improved vector safety, efficacy, and manufacturing, enabling better treatment selection.

Area of Science:

  • Biotechnology
  • Molecular Biology
  • Medical Science

Background:

  • Gene therapy involves delivering genetic material to somatic cells for disease treatment, relying on viral and non-viral vectors.
  • Early gene therapy clinical studies showed limited efficacy due to vector limitations.
  • A 2003 NIH Recombinant DNA Advisory Committee report highlighted the need for improved vector safety, gene expression control, and host interaction understanding.

Purpose of the Study:

  • To review advancements in gene delivery technology over the past six years.
  • To focus on improvements in vector safety, biodistribution analysis, and Good Manufacturing Practice (GMP) manufacturing.
  • To highlight new directions in enhancing gene therapy vector safety and efficacy.

Main Methods:

  • Review of progress in viral and non-viral gene transfer systems.

Related Experiment Videos

  • Analysis of vector safety and biodistribution data.
  • Examination of GMP manufacturing processes for gene therapy vectors.

    • Main Results:

    • Significant improvements in gene transfer vector safety and efficacy have been achieved.
    • Enhanced understanding of vector biodistribution and host interactions.
    • Development of robust GMP manufacturing processes for gene therapy vectors.
    • Data accumulation allows for informed vector selection based on performance in preclinical and clinical studies.

    Conclusions:

    • Gene therapy vector development has progressed substantially, addressing earlier limitations.
    • Improved vector technology facilitates more targeted and effective disease treatment strategies.
    • The field is moving towards more informed and optimized use of gene therapy vectors based on accumulated evidence.